Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
28 participants
INTERVENTIONAL
2022-10-05
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Is ESTS more effective than CBT in treating SPD?
2. Is ESTS more feasible than CBT in treating SPD?
38 patients diagnosed with SPD will be recruited and randomly allocated to either the experimental group (i.e. ESTS) or the control group (CBT). Primary outcome will be reduction in general symptomatology, whereas secondary outcomes will be changes in target mechanisms (self-criticism and metacognition) and remission from diagnosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Compassion and Metacognition in Schizotypal Personality
NCT04764708
An Evolutionarily Informed Conceptualization of Personality Pathology
NCT06623838
Assertive Community Treatment With CBT and SST for Schizophrenia
NCT02254733
Psychotherapy and Pharmacotherapy in Dissociative Disorders
NCT00630981
Modified Psychodynamic Psychotherapy for Patients With Schizophrenia
NCT02576613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thus, the investigators outlined an RCT aimed at comparing the two interventions (ESTS and CBT) without any mandatory pharmacological treatment. Moreover, the investigators consider the need for a pharmacological treatment during the study as an exclusion criterion.
The investigators expect to extend our knowledge about the feasbility and effectiveness of ESTS for those diagnosed with SPD:
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Behavioral Therapy
Cognitive Behavioral Therapy for Personality Disorder as manualized by Beck, Davis, Freeman and Beck in their book (2016) will be delivered to partecipants in the active control group.
Cognitive Behavioral Therapy
An adaptation of Cognitive Behavioral Therapy for those diagnosed with personaloty disorders.
Evolutionary Systems Therapy for Schizotypy
Evolutionary Systems Therapy for Schizotypy as manualized by Cheli and colleagues in their trial (2023) will be delivered to partecipants in the experimental group.
Evolutionary Systems Therapy for Schizotypy
A novel therapy for schizotypal traits integrating evolutionary psychopathology, compassion focused therapy, and metacognitively oriented psychotherapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evolutionary Systems Therapy for Schizotypy
A novel therapy for schizotypal traits integrating evolutionary psychopathology, compassion focused therapy, and metacognitively oriented psychotherapy.
Cognitive Behavioral Therapy
An adaptation of Cognitive Behavioral Therapy for those diagnosed with personaloty disorders.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 or older
* Being capable of reading and signing the inform consent form in Italian
* Being capable of attending a talk therapy in Italian
Exclusion Criteria
* Being diagnosed with neurodevelopmental or neurological disorders
* Being diagnosed with bipolar disorder
* Being under any psychological or pharmacological treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tages Onlus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simone Cheli, PhD
Role: PRINCIPAL_INVESTIGATOR
Tages Onlus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro di Psicologia e Psicoterapia Tages Onlus - Firenze
Florence, FI, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ESTS-23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.